Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Tofacitinib is an effective and safe treatment for alopecia areata.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Adverse reactions to isotretinoin in acne treatment are common and mainly linked to treatment duration.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.